Loading chat...
FL H2945
Bill
Status
Introduced
11/15/2021
Primary Sponsor
Demi Busatta Cabrera
Click for details
AI Summary
- Appropriates $796,706 from the General Revenue Fund to the Department of Children and Families for fiscal year 2022-2023
- Funds the DCF Extended-Release Injectable Naltrexone (Vivitrol) Program as described in Appropriations Project Request 536
- Designates the appropriation as nonrecurring funding
- Effective date is July 1, 2022
Legislative Description
Department of Children and Families (DCF) Extended-Release Injectable Naltrexone (Vivitrol) Program
Last Action
See HB 5001 (line item 371)
3/14/2022
Committee Referrals
Appropriations1/28/2022
Health Care Appropriations Subcommittee11/23/2021
Full Bill Text
No bill text available